SHILPAMED — Shilpa Medicare Share News
0.000.00%
Last trade - 00:00- IN₹184.31bn
- IN₹189.99bn
- IN₹15.39bn
Brief: Shilpa Medicare Enters Into Settlement With Celltrion
Brief: Shilpa Medicare Says US Approval For Varenicline Tablets
India's Shilpa Medicare gains on launch of new version of cancer drug
Brief: Shilpa Medicare Launches NDA Bortezomib For Injection In US
India's Shilpa Medicare rises as unit inks biologics deal with mAbTree Biologics
Brief: Shilpa Medicare Says Shilpa Biologicals Entered Into A Binding Term Sheet With Mabtree Biologics AG
Brief: Shilpa Medicare Says USFDA Inspection At Shilpa Pharma Unit-2 Closed With Zero Observations
Brief: Shilpa Medicare Says USFDA Conducts Inspection At Shilpa Pharma Unit-1
Brief: Shilpa Medicare Receives CDSCO Approval For Nor Ursodeoxycholic Acid Tablets
Brief: Shilpa Medicare Says Subsidiary Received Certificate Of Suitability From EDQM For API, Teriflunomide
Brief: Shilpa Medicare Gets Europe Approval For Tadalafil Orodisperible Films
Brief: Shilpa Medicare Gets Europe GMP Certificate For Unit VII, Nacharam, Hyderabad From EMA, Austria
Brief: Shilpa Medicare Says USFDA Approves NDA Imkeldi Filled By Partner Shorla Oncology
Brief: Shilpa Medicare Says Unit Received Cep From Edqm For API, Nifedipine
India's Shilpa Medicare gains as unit gets European regulator nod for drug
Brief: Shilpa Medicare Says Received CEP From EDQM For API, Octreotide
India's Shilpa Medicare gains after over 11-fold rise in Q2 profit
Brief: Shilpa Medicare Sept-Quarter Consol Net PAT 179.4 Mln Rupees
India's Shilpa Medicare falls on US FDA's inspection report